Literature DB >> 22430201

Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia.

M Huber1, M Kölzsch, M A Rapp, I Wulff, S Kalinowski, J Bolbrinker, W Hofmann, J Scholze, D Dräger, R Kreutz.   

Abstract

INTRODUCTION: The aim of this study was to investigate the frequency of benzodiazepines, antidementia and antipsychotic drug prescriptions in nursing home residents (NHR).Data of a German health insurance company were retrospectively analyzed for the year 2008.
METHODS: The study cohort comprised 13,042 NHR (82% women, mean age 83.6 ± 7 years). Following analgetics, antipsychotic drugs were the second most frequently prescribed drug group with 13.3% of all prescriptions. Dementia was diagnosed in 8 017 (61.5%) NHR. Thereof 51.6% received an antipsychotic, 17.3% a benzodiazepine and 15.2% an antidementia pharmaceutical, respectively. 18.1% of NHR with dementia and antipsychotic drug prescriptions were in combined treatment with antidementia pharmaceuticals. The rate of antipsychotic drug prescribing was significantly doubled in NHR with dementia compared to those without this diagnosis (p<0.01); the most frequently prescribed antipsychotics were melperone, risperidone and pipamperone. DISCUSSION: This study demonstrates the wide-spread use of psychotropic drugs in NHR. Moreover, dementia in NHR was associated with antipsychotic drug prescribing in every second patient. This highlights the need for further studies analyzing alternative treatments for dementia-related symptoms. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430201     DOI: 10.1055/s-0031-1301285

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  15 in total

1.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

2.  Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.

Authors:  June M Tordoff; Nagham J Ailabouni; Dorothy P Browne; Hesham S Al-Sallami; Andrew R Gray
Journal:  Int J Clin Pharm       Date:  2016-05-30

Review 3.  [Treatment with psychotropic agents in patients with dementia and delirium : Gap between guideline recommendations and treatment practice].

Authors:  Walter Hewer; Christine Thomas
Journal:  Z Gerontol Geriatr       Date:  2017-01-25       Impact factor: 1.281

4.  Drug-induced agranulocytosis in the Berlin case-control surveillance study.

Authors:  Matthias Huber; Frank Andersohn; Elisabeth Bronder; Andreas Klimpel; Michael Thomae; Christine Konzen; Oliver Meyer; Abdulgabar Salama; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Reinhold Kreutz; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2013-12-03       Impact factor: 2.953

Review 5.  [Complex treatment of severe mental illnesses in old age].

Authors:  Vjera Holthoff-Detto; André Nienaber; Nora Bötel; Michael Rapp
Journal:  Nervenarzt       Date:  2021-06-17       Impact factor: 1.214

6.  Medications use among women with dementia: a cohort study.

Authors:  Kailash Thapaliya; Melissa L Harris; Peta M Forder; Julie E Byles
Journal:  Aging Clin Exp Res       Date:  2021-05-26       Impact factor: 3.636

7.  Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use.

Authors:  Markus Wübbeler; Diana Wucherer; Johannes Hertel; Bernhard Michalowsky; Steffen Heinrich; Saskia Meyer; Susanne Schaefer-Walkmann; Wolfgang Hoffmann; Jochen René Thyrian
Journal:  BMC Health Serv Res       Date:  2015-05-22       Impact factor: 2.655

8.  Individual music therapy for agitation in dementia: an exploratory randomized controlled trial.

Authors:  Hanne Mette O Ridder; Brynjulf Stige; Liv Gunnhild Qvale; Christian Gold
Journal:  Aging Ment Health       Date:  2013-04-27       Impact factor: 3.658

9.  The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Francesco Salvo; Ariola Koci; Marc Suling; Stefania Antoniazzi; Luisella Perina; Lorna Hazell; Ugo Moretti; Miriam Sturkenboom; Edeltraut Garbe; Antoine Pariente; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

10.  Long-term effects of a 12 weeks high-intensity functional exercise program on physical function and mental health in nursing home residents with dementia: a single blinded randomized controlled trial.

Authors:  Elisabeth Wiken Telenius; Knut Engedal; Astrid Bergland
Journal:  BMC Geriatr       Date:  2015-12-03       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.